“Our data show that two doses of the four approved vaccines protect against the Delta variant, these data are reassuring. It is important to continue vaccination with particular attention to the most vulnerable people and the elderly. ”He said this Marco Cavaleri of the European Medicines Agency (Ema).
“Currently the EMA is unable to provide a definitive recommendation on the use of different anti-Covid vaccines for the two doses” of the vaccination course, but “preliminary data from studies in Spain and Germany show a good immune response and no security issues “. The head of vaccine strategy of the European Medicines Agency added. “The heterologous vaccination strategy has historically proven to be successful, has been used for other vaccines and has a solid scientific rationale,” Cavalieri concluded.
“All five treatments selected by the European Commission as part of its therapeutic strategy” against Covid-19 “are currently under continuous review by the EMA, which will continue during the summer. Initial opinions are expected later. the end of the year “. He also added the EMA.
REPRODUCTION RESERVED © Copyright ANSA
01 July 2021 15:24